Kalos Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-8,250
| Closed | -$252K | – | 222 |
|
|
2018
Q2 | $252K | Buy |
+8,250
| New | +$252K | 0.11% | 164 |
|
|
2018
Q1 | – | Sell |
-12,550
| Closed | -$232K | – | 223 |
|
|
2017
Q4 | $232K | Buy |
12,550
+50
| +0.4% | +$924 | 0.11% | 182 |
|
|
2017
Q3 | $146K | Sell |
12,500
-1,500
| -11% | -$17.5K | 0.09% | 141 |
|
|
2017
Q2 | $51K | Buy |
+14,000
| New | +$51K | 0.05% | 99 |
|